Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy

J Nucl Cardiol. 2022 Jun;29(3):1021-1029. doi: 10.1007/s12350-020-02396-7. Epub 2020 Oct 22.

Abstract

Background: Transthyretin amyloidosis (ATTR) is an occasional incidental finding on bone scintigraphy. We studied its prognostic impact in elderly patients.

Methods: The study population consisted of 2000 patients aged over 70 years who underwent bone scintigraphies with clinical indications in three nuclear medicine departments (Kymenlaakso, Jorvi and Meilahti hospitals) in Finland. All studies were performed using 99mTechnetium labeled hydroxymethylene diphosphonate (HMDP). ATTR was suspected in patients with ≥grade 2 Perugini grade uptake (grade 0-3). Heart-to-contralateral ratio (H/CL) of ≥ 1.30 was considered positive for ATTR. The overall and cardiovascular mortality were obtained from the Finnish National Statistical Service.

Results: There were a total of 1014 deaths (51%) and 177 cardiovascular deaths (9%) during median follow-up of 4 ± 2 years. ATTR was suspected in 69 patients (3.6%) of which 54 (2.7%) had grade 2 and 15 (.8%) had grade 3 uptake and in 47 patients (2.4%) by H/CL ratio. In multivariate analyses age, bone metastasis, H/CL ratio and grade 3 uptake were independent predictors of overall and cardiovascular mortality. Grade 2 uptake was a predictor of cardiovascular mortality.

Conclusions: A suspected ATTR as an incidental finding on bone scintigraphy predicts elevated overall and cardiovascular mortality in elderly patients.

Keywords: Amyloidosis; Bone scintigraphy; Transthyretin.

MeSH terms

  • Aged
  • Amyloid Neuropathies, Familial* / diagnostic imaging
  • Cardiovascular Diseases* / diagnostic imaging
  • Humans
  • Prognosis
  • Radionuclide Imaging
  • Tomography, X-Ray Computed

Supplementary concepts

  • Amyloidosis, Hereditary, Transthyretin-Related